Elucidation of different binding modes of purine nucleosides to human deoxycytidine kinase

Journal of Medicinal Chemistry

Volumn 51, Issue 14, 2008, Pages 4219-4225

  Sabini, Elisabetta ^a   Hazra, Saugata ^a   Konrad, Manfred ^b   Lavie, Arnon ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ARGININE; ASPARTIC ACID; CLADRIBINE; DEOXYCYTIDINE KINASE; DEOXYGUANOSINE; PURINE NUCLEOSIDE DERIVATIVE; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE;

ARTICLE; COMPLEX FORMATION; DRUG CONFORMATION; DRUG PROTEIN BINDING; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME KINETICS; ENZYME PHOSPHORYLATION; HYDROGEN BOND; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CLADRIBINE; CRYSTALLOGRAPHY, X-RAY; DEOXYCYTIDINE KINASE; HUMANS; MUTAGENESIS, SITE-DIRECTED; PROTEIN BINDING; PROTEIN CONFORMATION; PURINE NUCLEOSIDES;

EID: 47749102906     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800134t     Document Type: Article

References (22)

1. Goody, R. S.; Muller, B.; Restle, T. Factors contributing to the inhibition of HIV reverse transcriptase by chain-terminating nucleotides in vitro and in vivo. FEBS Lett. 1991, 291, 1-5.
2. White, J. C.; Capizzi, R. L. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells. Cancer Res. 1991, 51, 2559-2565.
3. Shewach, D. S.; Reynolds, K. K.; Hertel, L. Nucleotide specificity of human deoxycytidine kinase. Mol. Pharmacol. 1992, 42, 518-524.
4. Sabini, E.; Hazra, S.; Ort, S.; Konrad, M.; Lavie, A. Structural basis for substrate promiscuity of dCK. J. Mol. Biol. 2008, 378, 607-621
5. Datta, N. S.; Shewach, D. S.; Mitchell, B. S.; Fox, I. H. Kinetic properties and inhibition of human T lymphoblast deoxycytidine kinase. J. Biol. Chem. 1989, 264, 9359-9364.
6. Kawasaki, H.; Carrera, C. J.; Piro, L. D.; Saven, A.; Kipps, T. J.; et al. Relationship of deoxycytidine kinase and cytoplasmic 5′-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Blood 1993, 81, 597-601.
7. Sabini, E.; Ort, S.; Monnerjahn, C.; Konrad, M.; Lavie, A. Structure of human dCK suggests strategies to improve anticancer and antiviral therapy. Nat. Struct. Biol. 2003, 10, 513-519.
8. Godsey, M. H.; Ort, S.; Sabini, E.; Konrad, M.; Lavie, A. Structural basis for the preference of UTP over ATP in human deoxycytidine kinase: illuminating the role of main-chain reorganization. Biochemistry 2006, 45, 452-461.
9. Sabini, E.; Hazra, S.; Konrad, M.; Burley, S. K.; Lavie, A. Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase. Nucleic Acids Res. 2007, 35, 186-192.
10. Sabini, E.; Hazra, S.; Konrad, M.; Lavie, A. Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides. J. Med. Chem. 2007, 50, 3004-3014.
11. Saenger, W. Principles of Nucleic Acid Structure; Springer-Verlag: New York, 1984.
12. Hughes, T. L.; Hahn, T. M.; Reynolds, K. K.; Shewach, D. S. Kinetic analysis of human deoxycytidine kinase with the true phosphate donor uridine triphosphate. Biochemistry 1997, 36, 7540-7547.
13. Zhang, Y.; Secrist, J. A.; Ealick, S. E. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2006, 62, 133-139.
14. Kabsch, W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 1993, 26, 795-800.
15. Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. 1997, D53, 240-255.
16. Chai, J. J.; He, C.; Li, M.; Tang, L.; Luo, M. Crystal structure of carboxypeptidase A complexed with an inactivator in two crystal forms. Protein Eng. 1998, 11, 841-845.
17. Ennifar, E.; Carpentier, P.; Ferrer, J.-L.; Walter, P.; Dumas, P. X-ray-induced debromination of nucleic acids at the Br K absorption edge and implications for MAD phasing. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2002, 58, 1262-1268.
18. Olieric, V.; Ennifar, E.; Meents, A.; Fleurant, M.; Besnard, C.; et al. Using X-ray absorption spectra to monitor specific radiation damage to anomalously scattering atoms in macromolecular crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2007, 63, 759-768.
19. Agarwal, K. C.; Miech, R. P.; Parks, R. E., Jr. Guanylate kinases from human erythrocytes, hog brain, and rat liver. Methods Enzymol. 1978, 51, 483-490.
20. Kraulis, P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 1991, 24, 946-950.
21. Esnouf, R. An extensively modified version of molscript that includes greatly enhanced coloring capabilities. J. Mol. Graphics 1997, 15, 133-138.
22. Merrit, E. A.; Murphy, M. E. P. Raster3D version 2.0, a program for photorealistic molecular graphics. Acta Crystallogr. 1994, D50, 869-873.